NICE stands firm, but the public must learn to respect rationing

By Helen Mooney2007-09-20T00:00:00

When the High Court upheld NICE guidance on Alzheimer's drugs, it was seen as an endorsement of its fairness and credibility. But unless the public is better informed of resource issues, unrealistic demands for new drugs will continue to be an issue, writes Helen Mooney

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here